#ProstACT - Twitter Hashtag

8 months ago

#ProstACT Global: A phase 3 study of lutetium rosopatamab tetraxetan + Standard of Care vs Standard of Care alone in patients with metastatic castration-resistant #ProstateCancer. Presentation by Denise Guibault @TelixPharma. Presentation by @RKSayyid @UAUrology > https://t.co/q1DXxYhQaK @UroOnc

urotoday's tweet photo. #ProstACT Global: A phase 3 study of lutetium rosopatamab tetraxetan + Standard of Care vs Standard of Care alone in patients with metastatic castration-resistant #ProstateCancer. Presentation by Denise Guibault @TelixPharma. Presentation by @RKSayyid @UAUrology > https://t.co/q1DXxYhQaK @UroOnc

1

4

3

0

607

UroToday.com

@urotoday

about 2 years ago

#ProstACT GLOBAL: a phase 3 study of best SOC with and without 177Lu-DOTA-rosopatamab for pts with #PSMA expressing #mCRPC progressing despite prior treatment with a novel androgen axis drug - Oliver Sartor, MD @MayoClinic. #ASCO24 coverage > https://t.co/2t5j346Eod @RKSayyid

urotoday's tweet photo. #ProstACT GLOBAL: a phase 3 study of best SOC with and without 177Lu-DOTA-rosopatamab for pts with #PSMA expressing #mCRPC progressing despite prior treatment with a novel androgen axis drug - Oliver Sartor, MD @MayoClinic. #ASCO24 coverage > https://t.co/2t5j346Eod @RKSayyid https://t.co/iQGBXNEDaP

0

8

4

1

756

Telix Pharmaceuticals

@TelixPharma

over 3 years ago

Telix is pleased to present preliminary results from the Phase I ProstACT SELECT study of its antibody-based prostate cancer therapy candidate TLX591 at #ESUI22 in Budapest from 10-13 November. To find out more about the meeting visit: https://t.co/iv2Y18LXIV #ProstACT @Uroweb

TelixPharma's tweet photo. Telix is pleased to present preliminary results from the Phase I ProstACT SELECT study of its antibody-based prostate cancer therapy candidate TLX591 at #ESUI22 in Budapest from 10-13 November.

To find out more about the meeting visit: https://t.co/iv2Y18LXIV

#ProstACT @Uroweb https://t.co/zhImeLZY9L

0

10

1

0

Telix Pharmaceuticals

@TelixPharma

almost 4 years ago

With @GenesisCare we announce a first patient enrolled in the Phase II #ProstACT TARGET study of TLX591. TARGET will evaluate Telix's antibody-based therapy candidate in combination with external radiation in patients with earlier stage #ProstateCancer. https://t.co/DIYv1t6427

TelixPharma's tweet photo. With @GenesisCare we announce a first patient enrolled in the Phase II #ProstACT TARGET study of TLX591.

TARGET will evaluate Telix's antibody-based therapy candidate in combination with external radiation in patients with earlier stage #ProstateCancer.

https://t.co/DIYv1t6427 https://t.co/gtFl1lMGLZ

0

13

3

1

0

Telix Pharmaceuticals

@TelixPharma

about 4 years ago

Yesterday Telix presented #ProstACT SELECT at #ASCO22, a study comparing #68Ga- and #177Lu-PSMA biodistribution and tumour uptake in men with PSMA-expressing metastatic castrate-resistant #ProstateCancer (#mCRPC) progressing despite prior treatment with a novel androgen axis drug

TelixPharma's tweet photo. Yesterday Telix presented #ProstACT SELECT at #ASCO22, a study comparing #68Ga- and #177Lu-PSMA biodistribution and tumour uptake in men with PSMA-expressing metastatic castrate-resistant #ProstateCancer (#mCRPC) progressing despite prior treatment with a novel androgen axis drug https://t.co/prHXctAG9g

0

13

2

0

Telix Pharmaceuticals

@TelixPharma

over 4 years ago

Telix has been granted ethics for the #ProstACT TARGET Phase II study of TLX591. This trial will evaluate our antibody-based therapy candidate in patients experiencing a first recurrence of PSA after initial therapy for #prostatecancer. https://t.co/LLRy7a8XVT #TelixPharma

TelixPharma's tweet photo. Telix has been granted ethics for the #ProstACT TARGET Phase II study of TLX591.

This trial will evaluate our antibody-based therapy candidate in patients experiencing a first recurrence of PSA after initial therapy for #prostatecancer.

https://t.co/LLRy7a8XVT

#TelixPharma https://t.co/yuXyLp4PAY

0

10

1

0

Telix Pharmaceuticals

@TelixPharma

over 4 years ago

We are pleased to announce a first patient has been dosed in Telix's #ProstACT therapeutic program, exploring TLX591 in #ProstateCancer. Thanks to Professor Kenneth O’Byrne and his team at @pahospital, and the patients who will contribute to the study. https://t.co/nwmDwo3hDp

TelixPharma's tweet photo. We are pleased to announce a first patient has been dosed in Telix's #ProstACT therapeutic program, exploring TLX591 in #ProstateCancer.

Thanks to Professor Kenneth O’Byrne and his team at @pahospital, and the patients who will contribute to the study.

https://t.co/nwmDwo3hDp https://t.co/dcpfl7Rdi7

0

16

4

0

Telix Pharmaceuticals

@TelixPharma

almost 5 years ago

We are pleased to announce the expansion of our #ProstACT program including a collaboration with Telix's strategic partner @GenesisCare, extending evaluation of the TLX591 platform into areas of unmet need across the full prostate cancer treatment journey https://t.co/fcqcwSJ3BB

TelixPharma's tweet photo. We are pleased to announce the expansion of our #ProstACT program including a collaboration with Telix's strategic partner @GenesisCare, extending evaluation of the TLX591 platform into areas of unmet need across the full prostate cancer treatment journey

https://t.co/fcqcwSJ3BB https://t.co/qyTLTgnnP1

0

12

1

0

Gabriel Liberatore

@GabLiberatore

about 5 years ago

A significant Milestone by @TelixPharma #TelixPharma #SeeItTreatIt #ProstateCancer #PSMA #PROSTACT

Telix Pharmaceuticals

@TelixPharma

about 5 years ago

We're pleased to announce the commencement of Telix's ProstACT Phase III study for TLX591, bringing us a step closer to delivering on a major unmet medical need for treatment options in patients with advanced prostate cancer. https://t.co/8e8uGfWEPv #TelixPharma #ProstateCancer

TelixPharma's tweet photo. We're pleased to announce the commencement of Telix's ProstACT Phase III study for TLX591, bringing us a step closer to delivering on a major unmet medical need for treatment options in patients with advanced prostate cancer.

https://t.co/8e8uGfWEPv

#TelixPharma #ProstateCancer https://t.co/worN7KuM3Q

0

12

6

0

3

0

Top Tweets for #ProstACT

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users